SPY422.49+0.38 0.09%
DIA339.11-1.65 -0.48%
IXIC14,176.70+137.02 0.98%

BRIEF-TG Therapeutics Reports Q1 Loss Per Share Of $0.69

05/10/2021 08:08
BRIEF-TG Therapeutics Reports Q1 Loss Per Share Of $0.69

- TG Therapeutics Inc TGTX.O:

  • TG THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS

  • TG THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES WERE $523.8 MILLION AS OF MARCH 31, 2021,

  • TG THERAPEUTICS - CASH, CASH EQUIVALENTS, INVESTMENT SECURITIES AS OF MAR 31, WILL BE SUFFICIENT TO FUND COMPANY'S PLANNED OPERATIONS INTO 2023

  • TG THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.69

Source text for Eikon: ID:nGNX9hRwl

Further company coverage: TGTX.O


(([email protected];))